Literature DB >> 28687581

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, Jessica K Altman, Frederick R Appelbaum, Daniel A Arber, Vijaya Bhatt, Dale Bixby, William Blum, Steven E Coutre, Marcos De Lima, Amir T Fathi, Melanie Fiorella, James M Foran, Steven D Gore, Aric C Hall, Patricia Kropf, Jeffrey Lancet, Lori J Maness, Guido Marcucci, Michael G Martin, Joseph O Moore, Rebecca Olin, Deniz Peker, Daniel A Pollyea, Keith Pratz, Farhad Ravandi, Paul J Shami, Richard M Stone, Stephen A Strickland, Eunice S Wang, Matthew Wieduwilt, Kristina Gregory, Ndiya Ogba.   

Abstract

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and provides recommendations on the workup, diagnostic evaluation, and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.
Copyright © 2017 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2017        PMID: 28687581     DOI: 10.6004/jnccn.2017.0116

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  108 in total

Review 1.  Core binding factor acute myeloid leukemia: Advances in the heterogeneity of KIT, FLT3, and RAS mutations (Review).

Authors:  Xi Quan; Jianchuan Deng
Journal:  Mol Clin Oncol       Date:  2020-05-25

Review 2.  Cytotoxic therapy in acute myeloid leukemia: not quite dead yet.

Authors:  Laura C Michaelis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States.

Authors:  Vijaya Raj Bhatt; Valerie Shostrom; Krishna Gundabolu; James O Armitage
Journal:  Blood Adv       Date:  2018-06-12

4.  Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline.

Authors:  Valérie de Haas; Nofisat Ismaila; Anjali Advani; Daniel A Arber; Raetasha S Dabney; Dipti Patel-Donelly; Elizabeth Kitlas; Rob Pieters; Ching-Hon Pui; Kendra Sweet; Ling Zhang
Journal:  J Clin Oncol       Date:  2018-12-03       Impact factor: 44.544

5.  Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study.

Authors:  Guillermo Garcia-Manero; Yasmin Abaza; Koichi Takahashi; Bruno C Medeiros; Martha Arellano; Samer K Khaled; Mrinal Patnaik; Olatoyosi Odenike; Hamid Sayar; Mohan Tummala; Prapti Patel; Lori Maness-Harris; Robert Stuart; Elie Traer; Kasra Karamlou; Abdulraheem Yacoub; Richard Ghalie; Ruben Giorgino; Ehab Atallah
Journal:  Blood Adv       Date:  2019-02-26

6.  Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients.

Authors:  Fan Zhou; Fen Zhou; Mengyi Du; Lin Liu; Tao Guo; Linghui Xia; Runming Jin; Yu Hu; Heng Mei
Journal:  Int J Hematol       Date:  2019-08-22       Impact factor: 2.490

7.  Allogeneic hematopoietic cell transplantation efficacy in patients with Philadelphia chromosome-positive acute myeloid leukemia in complete remission.

Authors:  Shohei Mizuno; Masamitsu Yanada; Koji Kawamura; Masayoshi Masuko; Naoyuki Uchida; Yukiyasu Ozawa; Koji Iwato; Kazuteru Ohashi; Kazuhiro Ikegame; Sung-Won Kim; Masatsugu Tanaka; Tetsuya Eto; Yoshinobu Kanda; Takahiro Fukuda; Yoshiko Atsuta; Shingo Yano; Akiyoshi Takami
Journal:  Bone Marrow Transplant       Date:  2020-07-31       Impact factor: 5.483

8.  Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study.

Authors:  Takeshi Takahashi; Kensuke Usuki; Kosei Matsue; Hitoshi Ohno; Toru Sakura; Ryota Imanaka; Masato Murakami; Shoichi Ohwada; Taiga Takagi; Sakura Sakajiri
Journal:  Int J Hematol       Date:  2019-08-31       Impact factor: 2.490

9.  Immunorelated gene polymorphisms associated with acute myeloid leukemia.

Authors:  Q Liu; M Hua; S Yan; C Zhang; R Wang; X Yang; F Han; M Hou; D Ma
Journal:  Clin Exp Immunol       Date:  2020-06-02       Impact factor: 4.330

Review 10.  Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy.

Authors:  Shaheedul A Sami; Noureldien H E Darwish; Amanda N M Barile; Shaker A Mousa
Journal:  Curr Treat Options Oncol       Date:  2020-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.